newsfilter
← Latest News
ClinicalTrials.gov·

Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy - NCT05560659

Evaluate the (bPFS) of SABR alone and SABR + 177Lu-PSMA, The AEs according to CTCAE v5.0, The PSA-response rate, (and 6 more...)